Table 2 Rates and frequencies of exposure during the follow-up time
Variable Group | Variable | Value |
|---|---|---|
Socio-demographic variables | Female; N (%) | 193,992 (56.5%) |
Age at index date; mean (SD) | 30.5 (13.3) | |
Socioeconomic status; N (%) | ||
quintile 1 | 38,501 (11.2%) | |
quintile 2 | 52,581 (15.3%) | |
quintile 3 | 65,695 (19.1%) | |
quintile 4 | 81,610 (23.8%) | |
quintile 5 | 102,534 (29.8%) | |
Unknown/missing | 2599 (0.8%) | |
Type and quality of carefor asthma (measured in the previous year)* | Having received pulmonary function test | 82,765 (3.2%) |
Respirologist consultation | 47,957 (1.8%) | |
Internal medicine consultation | 28,501 (1.1%) | |
Allergist consultation | 35,405 (1.3%) | |
General Practitioner visits | ||
No visit | 1,803,958 (68.8%) | |
1 visit | 452,950 (17.3%) | |
2 visits | 199,816 (7.6%) | |
More than 2 visits | 166,341 (6.3%) | |
Continuity of care (COC) | ||
COC = 0 | 275,396 (10.5%) | |
COC > 0 and COC < 50% | 2,065,128 (78.7%) | |
COC > =50% and COC < 100% | 205,991 (7.9%) | |
COC = 100% | 76,550 (2.9%) | |
History of asthma hospitalisation | 9936 (0.4%) | |
Ratio of ICS to total asthma medications being more than 50% | 776,182 (29.6%) | |
Use of systemic corticosteroids | 330,381 (12.6%) | |
Comorbidity (measured in the previous year) | Modified Charlson score (SD) | 0.1 (2.0) |
None asthma related outpatient resource use | ||
< 5 times outpatient service use | 543,505 (20.7%) | |
<=5 and > 10 times outpatient service use | 615,599 (23.5%) | |
<=10 and > 20 times outpatient service use | 750,000 (28.6%) | |
> 20 times outpatient service use | 713,961 (27.2%) | |
Non-asthma related hospitalisation | 417,864 (15.9%) |